Description
The goal of this study is to further characterise the potential long-term safety risks of lonapegsomatropin in patients treated with lonapegsomatropin under real-world conditions in the post-marketing setting.
Location: SIMR (Sacramento/Valley Area)
Please contact: SIMR@sutterhealth.org about SkyPass